Cargando…

Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea

The incidence of gastroesophageal junction adenocarcinoma (GEJAC) in Western countries has increased in recent decades, in addition to a rise in the incidence of esophageal adenocarcinoma (EAC). Gastroesophageal reflux disease (GERD), obesity, smoking, alcohol consumption, and low Helicobacter pylor...

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, Jin-Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310763/
https://www.ncbi.nlm.nih.gov/pubmed/30607296
http://dx.doi.org/10.5230/jgc.2018.18.e38
_version_ 1783383491008790528
author Kim, Jin-Jo
author_facet Kim, Jin-Jo
author_sort Kim, Jin-Jo
collection PubMed
description The incidence of gastroesophageal junction adenocarcinoma (GEJAC) in Western countries has increased in recent decades, in addition to a rise in the incidence of esophageal adenocarcinoma (EAC). Gastroesophageal reflux disease (GERD), obesity, smoking, alcohol consumption, and low Helicobacter pylori (HP) infection rate have been nominated as risk factors for such cancers. Among these risk factors, the increased prevalence of GERD and obesity and the decreased prevalence of HP infection are of special interest owing to the currently increasing prevalence of GEJAC in Western countries. Although similar trends in the prevalence of GERD, obesity, and HP infection are observed in Asian countries after a time lag from Western countries, it is still uncertain if the prevalence of GEJAC in Asian countries is increasing, especially in Korea. The incidence of GERD in Korea is currently increasing; it was below 3% in the 1990s. The incidence of obesity in the Korean population is increasing owing to the adoption of westernized lifestyles, including food preferences, and the HP infection rate in Korea is known to be decreasing. Therefore, based on logical extrapolation of observations of Western countries, the incidence of GEJAC will increase in Korea. However, the proportion of GEJAC among other upper gastrointestinal malignancies in Korea appears to be currently unchanged compared with that in the 1990s. Presently, there is a lack of epidemiologic studies on this issue in this region; therefore, more studies are needed to clarify the characteristics of these tumors and to improve clinical outcomes for patients with these tumors.
format Online
Article
Text
id pubmed-6310763
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Gastric Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-63107632019-01-03 Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea Kim, Jin-Jo J Gastric Cancer Review Article The incidence of gastroesophageal junction adenocarcinoma (GEJAC) in Western countries has increased in recent decades, in addition to a rise in the incidence of esophageal adenocarcinoma (EAC). Gastroesophageal reflux disease (GERD), obesity, smoking, alcohol consumption, and low Helicobacter pylori (HP) infection rate have been nominated as risk factors for such cancers. Among these risk factors, the increased prevalence of GERD and obesity and the decreased prevalence of HP infection are of special interest owing to the currently increasing prevalence of GEJAC in Western countries. Although similar trends in the prevalence of GERD, obesity, and HP infection are observed in Asian countries after a time lag from Western countries, it is still uncertain if the prevalence of GEJAC in Asian countries is increasing, especially in Korea. The incidence of GERD in Korea is currently increasing; it was below 3% in the 1990s. The incidence of obesity in the Korean population is increasing owing to the adoption of westernized lifestyles, including food preferences, and the HP infection rate in Korea is known to be decreasing. Therefore, based on logical extrapolation of observations of Western countries, the incidence of GEJAC will increase in Korea. However, the proportion of GEJAC among other upper gastrointestinal malignancies in Korea appears to be currently unchanged compared with that in the 1990s. Presently, there is a lack of epidemiologic studies on this issue in this region; therefore, more studies are needed to clarify the characteristics of these tumors and to improve clinical outcomes for patients with these tumors. The Korean Gastric Cancer Association 2018-12 2018-12-13 /pmc/articles/PMC6310763/ /pubmed/30607296 http://dx.doi.org/10.5230/jgc.2018.18.e38 Text en Copyright © 2018. Korean Gastric Cancer Association https://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kim, Jin-Jo
Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
title Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
title_full Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
title_fullStr Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
title_full_unstemmed Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
title_short Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea
title_sort epidemiology of gastroesophageal junction adenocarcinoma in korea
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310763/
https://www.ncbi.nlm.nih.gov/pubmed/30607296
http://dx.doi.org/10.5230/jgc.2018.18.e38
work_keys_str_mv AT kimjinjo epidemiologyofgastroesophagealjunctionadenocarcinomainkorea